You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.


Go back


In COPD, we are passionate about advancing medicine to ensure the right medicine gets to the right patient, with a simplified approach across the disease spectrum.

Explore COPD

Severe asthma

We understand how difficult it can be to manage patients with severe asthma. We’re here to help you identify patients who might benefit from additional treatments.

Ellipta was developed in collaboration with